Patents by Inventor Karen L. Lasch

Karen L. Lasch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE
    Publication number: 20240376210
    Abstract: A method for treating a human patient suffering from fistulizing Crohn's disease, comprising administering to a patient suffering from fistulizing Crohn's disease, a humanized antibody having binding specificity for human ?4?7 integrin, wherein the human patient has a seton that was surgically placed prior to administration of the antibody, and wherein the dosing regimen induces fistula (e) healing.
    Type: Application
    Filed: December 11, 2023
    Publication date: November 14, 2024
    Inventor: Karen L. LASCH
  • Vedolizumab for the treatment of fistulizing Crohn's disease
    Patent number: 11884731
    Abstract: A method for treating a human patient suffering from fistulizing Crohn's disease, comprising administering to a patient suffering from fistulizing Crohn's disease, a humanized antibody having binding specificity for human ?4?7 integrin, wherein the human patient has a seton that was surgically placed prior to administration of the antibody, and wherein the dosing regimen induces fistula(e) healing.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: January 30, 2024
    Assignee: Takeda Pharmaceutical Company Limited
    Inventor: Karen L. Lasch
  • VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE
    Publication number: 20200031937
    Abstract: A method for treating a human patient suffering from fistulizing Crohn's disease, comprising administering to a patient suffering from fistulizing Crohn's disease, a humanized antibody having binding specificity for human ?4?7 integrin, wherein the human patient has a seton that was surgically placed prior to administration of the antibody, and wherein the dosing regimen induces fistula(e) healing.
    Type: Application
    Filed: March 11, 2019
    Publication date: January 30, 2020
    Inventor: Karen L. Lasch
  • Vedolizumab for the Treatment of Fistulizing Crohn's Disease
    Publication number: 20170327584
    Abstract: A method for treating a human patient suffering from fistulizing Crohn's disease, comprising administering to a patient suffering from fistulizing Crohn's disease, a humanized antibody having binding specificity for human ?4?7 integrin, wherein the human patient has a seton that was surgically placed prior to administration of the antibody, and wherein the dosing regimen induces fistula(e) healing.
    Type: Application
    Filed: November 25, 2015
    Publication date: November 16, 2017
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventor: Karen L. Lasch